|
CPT2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.599000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.524400E-01 |
| Normal-vs-Stage2 |
8.042500E-04 |
| Normal-vs-Stage3 |
3.555400E-01 |
| Normal-vs-Stage4 |
1.118790E-01 |
| Stage1-vs-Stage2 |
1.758600E-03 |
| Stage1-vs-Stage3 |
8.025600E-02 |
| Stage1-vs-Stage4 |
2.902200E-02 |
| Stage2-vs-Stage3 |
1.556980E-04 |
| Stage2-vs-Stage4 |
5.51100000000249E-05 |
| Stage3-vs-Stage4 |
4.237200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.139600E-01 |
| Normal-vs-AfricanAmerican |
8.349200E-01 |
| Normal-vs-Asian |
6.031800E-01 |
| Caucasian-vs-AfricanAmerican |
9.105400E-01 |
| Caucasian-vs-Asian |
5.343000E-01 |
| AfricanAmerican-vs-Asian |
5.920000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.302400E-01 |
| Normal-vs-Female |
3.519000E-01 |
| Male-vs-Female |
4.321400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.625200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.874200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.364300E-02 |
| Normal-vs-Age(81-100Yrs) |
5.177200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.092600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.791900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.574400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.068300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.585200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.672370E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.06269999999398E-05 |
| Classical-VS-Follicular |
4.10660000449425E-08 |
| Classical-VS-Other |
2.178400E-01 |
| Classical-VS-Normal |
8.113600E-01 |
| Tall-VS-Follicular |
2.05058192648266E-13 |
| Tall-VS-Other |
8.753000E-01 |
| Tall-VS-Normal |
3.974600E-04 |
| Follicular-VS-Other |
8.817600E-03 |
| Follicular-VS-Normal |
1.21149999998682E-06 |
| Other-VS-Normal |
1.010990E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.155700E-03 |
| Normal-vs-N1 |
2.477100E-03 |
| N0-vs-N1 |
8.86919999665281E-08 |
|
|
